EBOLA VIRUS: AN OVERVIEW
Journal Title: Asian Journal Of Pharmaceutical Research and Development - Year 2017, Vol 5, Issue 3
Abstract
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF) or simply Ebola, is a viral hemorrhagic fever of humans and other primates caused by ebola viruses. Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscular pain, and headaches. Then, vomiting, diarrhea and rash usually follow, along with decreased function of the liver and kidneys. At this time some people begin to bleed both internally and externally. The disease has a high risk of death, killing between 25 and 90 percent of those infected, with an average of about 50 percent. This is often due to low blood pressure from fluid loss, and typically follows six to sixteen days after symptoms appear. The virus spreads by direct contact with body fluids, such as blood, of an infected human or other animals. This may also occur through contact with an item recently contaminated with bodily fluids. Spread of the disease through the air between primates, including humans, has not been documented in either laboratory or natural conditions. Semen or breast milk of a person after recovery from EVD may carry the virus for several weeks to months. Fruit bats are believed to be the normal carrier in nature, able to spread the virus without being affected by it. Other diseases such as malaria, cholera, typhoid fever, meningitis and other viral hemorrhagic fevers may resemble EVD.
Authors and Affiliations
Shubham Gautam
Keywords
Related Articles
- EP ID EP303300
- DOI -
- Views 111
- Downloads 0
ASSESSMENT OF MAJOR COMPLICATIONS IN PREGNANCY: A SINGLE CENTER STUDY
Pregnancy complications in our country are common in spite of a lot of progress made in antenatal care of pregnant women in the recent times. The complications range from simple anemia to ectopic pregnancy. We conducted...
TERPENOIDS AND PHYTOSTEROLS ISOLATED FROM PLUMERIA RUBRA L., FORM ACUTIFOLIA (AIT) WOODSON AND ITS FUNGUS PARASITE COLESPORIUM PLUMERIAE
The hexane and ethyl acetate extracts of the leaves from Plumeria rubra L., form acutifolia (Ait) Woodson and the methanolic extract from the fungus Coleosporium plumeriae Pat. were analized by high resolution gas chroma...
REVIEW ON VENDOR AUDIT MANAGEMENT
Vendor Relationship Management (SRM), is systematic planning and managing of all interactions with suppliers to maximize its value. Its application varies from construction industries to healthcar...
REGULATORY PERSPECTIVE OF BIOSIMILARS IN INDIA
Biosimilar drugs are follow-on versions of original biopharmaceutical medicines. They are independently developed after the patent protecting the original product has expired. Biosimilars are designed to target specific...
CIPROFLOXACIN HYDROCHLORIDE LOADED CHITOSAN NANOPARTICLE GEL: ADVANCED APPROACH FOR ENHANCING PERMEATION AND SUSTAINABILITY OF DRUG RELEASE
Transdermal drug delivery is one of the most reliable, appealing and effective technique which provides controlled and constant administration of drug. The aim of the study was to develop a gel form of n...